Paris-Trousseau syndrome : clinical, hematological, molecular data of ten new cases

Summary

Paris-Trousseau syndrome (PTS) is an inherited disorder char-acterized by mild hemorragic tendency associated with 11q chromosome deletion. Here we report ten new patients (5 boys,5 girls) with complete clinical history, biological data, ultra-structural and molecular investigations. Thrombocytopenia is chronic in all the patients except two boys in whom it disappeared during the two first years of life. On Romanovsky stained peripheral blood smears, abnormal platelets with giant granules were detected in all the children and confirmed by electron microscopy (EM). On bone marrow smears, dysmega-karyopoiesis with many micromegakaryocytes was constantly observed. Abnormal alpha-granules were virtually absent from bone marrow and cultured megakaryocytes, while EM detected numerous images of granule fusion within blood platelets. Molecular analyses evidenced that the fli-1 gene is deleted in all the patients except one confirming the crucial role of the transcription factor FLI-1 in megakaryopoiesis. In summary, this study documents ten new cases of PTS with characteristic alpha-granule abnormalities, and shows the putative pathogenic role of fli-1 gene in the pathophysiology of this syndrome.

Keywords

Paris Trousseau syndrome - giant alpha–granule - 11q 23 deletion - fli-1 gene

• References

• 1 Favier R, Douay L, Esteva B. et al A novel genetic thrombocytopenia (Paris-Trousseau) associated with platelet inclusions, dysmegakaryopoiesis and chromosome deletion at 11q 23. CR Acad Sci Paris 1993; 316: 698-701.
• 2 Breton-Gorius J, Favier R, Guichard J. et al A new congenital dysmegakaryopoiesis thrombocytopenia (Paris-Trousseau) associated with giant platelets and chromosome 11 deletion at 11q23. Blood 1995; 85: 1805-14.
• 3 Smith MP, Cramer EM, Savidge GF. Mega-karyocytes and platelets in alpha-granule disorders. In: Caen JP, Han ZC, eds. Mega-karyocytes and platelet disorders. Vol 10, No.1. Baillière’s Clinical Haematology 1997; 125-47.
• 4 Michaelis RC, Velagaleti GVN, Jones C. et al Most Jacobsen syndrome deletion breakpoints occur distal to FRA11B. Am J Med Genet 1998; 76: 222-8.
• 5 Gadner H, Haass OA. Experience in pediatric myelodysplasic syndromes. In Hemato/Oncol Clin North Am 1992; 6 (03) 655-72.
• 6 Hart A, Melet F, Grossfeld P. et al. Fli-1 is required for murine vascular and megakaryocytic development and is hemizygously deleted in patients with thrombocytopenia. Immunity 2000; 13: 167-177.
• 7 Jacobsen P, Hauge M, Henningsen K. et al An (11,21) translocation in four generation with chromosome 11 abnormalities in the offspring. A clinical, cytogenetical and gene marker study. Hum Hered 1973; 23: 568-85.
• 8 Van Hemel JO, Eussen B, Wesby Van Swaay E. et al Molecular detection of a translocation (Y;11)(q11.2;q24) in a 45 X male with signs of Jacobsen syndrome. Hum Genet 1992; 88: 661-67.
• 9 Penny LA, Dell’Aquila M, Jones MC. et al Clinical and molecular characterization of patients with distal 11q deletion. Am J Hum Genet 1995; 56: 676-83.
• 10 Ono J, Hasegawa T, Sugama N. et al. Partial deletion of the long arm of chromosome 11: ten Japanese children. Clin Genet 1996; 50: 474-8.
• 11 Jones C, Penny L, Mattina T. et al Association of a chromosome deletion syndrome with a fragile site within the proto-oncogene CBL2. Nature 1995; 376: 145-9.
• 12 Gangarossa S, Schiliro G, Mattina T. et al Dysmegakaryopoietic thrombocytopenia in patients with distal chromosome partial deletion of 11 q deletion. Blood 1996; 87: 4915-6.
• 13 Lin JH, Hou JW, Teng RJ. et al. Jacobsen distal deletion syndrome with a myelodysplastic change of hemopoietic cells. Am J Hum Genet 1998; 75: 341-44.
• 14 Krishnamurti L, Neglia JP, Nagarajan R. et al Paris-Trousseau syndrome platelets in a child with Jacobsen’s syndrome. Am J Hematol 2001; 66: 295-9.